Gauging viral transmission through human mobility in order to contain the COVID-19 pandemic has been a hot topic in academic studies and evidence-based policy-making. Although it is widely accepted that there is a strong positive correlation between the transmission of the coronavirus and the mobility of the general public, there are limitations to existing studies on this topic. For example, using digital proxies of mobile devices/apps may only partially reflect the movement of individuals; using the mobility of the general public and not COVID-19 patients in particular, or only using places where patients were diagnosed to study the spread of the virus may not be accurate; existing studies have focused on either the regional or national spread of COVID-19, and not the spread at the city level; and there are no systematic approaches for understanding the stages of transmission to facilitate the policy-making to contain the spread.To address these issues, we have developed a new methodological framework for COVID-19 transmission analysis based upon individual patients’ trajectory data. By using innovative space–time analytics, this framework reveals the spatiotemporal patterns of patients’ mobility and the transmission stages of COVID-19 from Wuhan to the rest of China at finer spatial and temporal scales. It can improve our understanding of the interaction of mobility and transmission, identifying the risk of spreading in small and medium-sized cities that have been neglected in existing studies. This demonstrates the effectiveness of the proposed framework and its policy implications to contain the COVID-19 pandemic.
Background:
With the global spreading of Coronavirus disease (COVID-19), many primary care medical workers have been infected, particularly in the early stages of this pandemic. Although extensive studies have explored the COVID-19 transmission patterns and (non-) pharmaceutical intervention to protect the general public, limited research has analysed the measures to prevent nosocomial transmission based upon detailed interpersonal contacts between medical staff and patients.
Aim:
This paper aims to develop and evaluate proactive prevention measures to contain the nosocomial transmission of COVID-19. The specific objectives are (1) to understand the virus transmission via interpersonal contacts among medical staff and patients; (2) to define proactive measures to reduce the risk of infection of medical staff and (3) evaluate the effectiveness of these measures to control the COVID-19 epidemic in hospitals.
Methods:
We observed the operation of a typical primary hospital in China to understand the interpersonal contacts among medical staff and patients. We defined effective distance as the indicator for risk of transmission. Then three proactive measures were proposed based upon the observations, including a medical staff rotation system, the establishment of a separate fever clinic and medical staff working alone. Finally, the impacts of these measures are evaluated with a modified Susceptible-Exposure-Infected-Removed model accommodating the situation of hospitals and asymptomatic and latent infection of COVID-19. The case study was conducted with the hospital observed in December 2019 and February 2020.
Findings:
The implementation of the medical staff rotation system has the most significant impact on containing the epidemic. The establishment of a separate fever clinic and medical staff working alone also benefits from inhibiting the epidemic outbreak. The simulation finds that if effective prevention and control measures are not taken in time, it will lead to a surge of infection cases in all asymptomatic probabilities and incubation periods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.